Benztropine for MS

Although the secondary progressive multiple sclerosis space is filling up with new compounds, few have shown the ability to remyelinate neurons. A new study suggests that an ancient Parkinson's disease drug-benztropine-could accomplish that task in secondary progressive multiple sclerosis, although it might require reformulation to improve activity and specificity.¹

There are multiple immunomodulatory therapies on the market that stop or slow the autoimmune attack on neurons by myelin-specific ...